↓ Skip to main content

Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer

Overview of attention for article published in Breast Cancer Research, May 2012
Altmetric Badge

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
58 Mendeley